Video

Dr. Chase on Utilizing Genetic Testing to Guide Treatment Decisions in Ovarian Cancer

Dana Chase, MD, FACOG, discusses the importance of utilizing genetic testing to guide treatment decisions for patients with ovarian cancer.

Dana Chase, MD, FACOG, a gynecologic oncologist at Arizona Oncology, and an assistant professor at the University of Arizona College of Medicine, discusses the importance of utilizing genetic testing to guide treatment decisions for patients with ovarian cancer.

Over the past few years, the frontline treatment of patients with ovarian cancer has changed with the emergence of new options in the armamentarium, according to Chase. Treatment decisions can be made more rapidly, directly after biopsy or surgery, when genetic testing is performed and results are obtained, Chase says.

Utilizing certain biomarkers to guide treatment at diagnosis is a significant shift in the treatment of this population, Chase notes. The exact course of treatment for each patient can vary; however, there are options that can be impactful if they are chosen based on genetic or homologous recombination deficiency testing results, Chase concludes.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity